Chargement en cours...
Lack of Glibenclamide Response in a Case of Permanent Neonatal Diabetes Caused by Incomplete Inactivation of Glucokinase
Background: Hypoglycaemic drugs that close the K(ATP) channel have been tested in patients with permanent neonatal diabetes due to glucokinase mutations (PNDM-GCK). From the results obtained, it has been suggested that this treatment may be beneficial in patients carrying GCK mutations with mild kin...
Enregistré dans:
| Publié dans: | JIMD Rep |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Springer Berlin Heidelberg
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4375116/ https://ncbi.nlm.nih.gov/pubmed/25665835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/8904_2014_383 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|